Responses
Plenary 02: Changing the Landscape of Endometrial Cancer
AS04. Endometrial/Uterine corpus cancers
PO006LBA/#1520 Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Compose a Response to This Article
Other responses
No responses have been published for this article.